ScottLFriedmanMD

Gastroenterology • New York, NY

Hepatology & Liver Transplantation

Professor, Medicine, Icahn School of Medicine

Join to view full profile

Dr. Friedman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Friedman's full profile

Already have an account?

Office
1 Gustave L Levy Pl
New York, NY 10029
Phone+1 212-241-7270

Fax+1 212-241-4465

Education & Training

University of California (San Francisco)Fellowship, Gastroenterology, 1982 - 1985
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1980 - 1982
Icahn School of Medicine at Mount SinaiClass of 1979

Certifications & Licensure

CA State Medical License 1982 - Present
NY State Medical License 1997 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

Fellow (AGAF) American Gastroenterological Association, 2007
Elected Member The American Society for Clinical Investigation, 1995
Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

2305 citations
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman, Brent A. Neuschwander-Tetri, Mary E. Rinella, Arun J. Sanyal
Nature Medicine. 2018-07-02
3 citations
Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatohepatitis.
Chittampalli N Yashaswini, Tianyue Qin, Dipankar Bhattacharya, Corina Amor, Scott Lowe
Journal of Hepatology. 2024-08-01
830 citations
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell. 2021-05-13

Journal Articles

Autophagy Is a Gatekeeper of Hepatic Differentiation and Carcinogenesis by Controlling the Degradation of Yap
Kirk N Campbell, Mark J Czaja, M Isabel Fiel, Kemal M Akat, Scott L Friedman, Nature
Mechanisms of NAFLD Development and Therapeutic Strategies
Arun J Sanyal, Mary Rinella, Scott L Friedman, Nature

Other

Acetaminophen (paracetamol) poisoning in adults: Pathophysiology, presentation, and diagnosis
Friedman SL, Larson AM, Burns MJ
http://www.uptodate.com/contents/acetaminophen-paracetamol-poisoning-in-adults-pathophysiology-prese
UpToDate, Wolters Kluwer Health - 2013-01-12
Alcoholic hepatitis: Clinical manifestations and diagnosis
Friedman SL
http://www.uptodate.com/contents/alcoholic-hepatitis-clinical-manifestations-and-diagnosis
UpToDate, Wolters Kluwer Health - 2013-02-19
Alcoholic hepatitis: Natural history and management
Friedman SL
http://www.uptodate.com/contents/alcoholic-hepatitis-natural-history-and-management
UpToDate, Wolters Kluwer Health - 2013-01-29
Clinical manifestations and diagnosis of alcoholic fatty liver disease and alcoholic cirrhosis
Friedman SL
http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-alcoholic-fatty-liver-dise
UpToDate, Wolters Kluwer Health - 2013-01-29
Prognosis and management of alcoholic fatty liver disease and alcoholic cirrhosis
Friedman SL
http://www.uptodate.com/contents/prognosis-and-management-of-alcoholic-fatty-liver-disease-and-alcoh
UpToDate, Wolters Kluwer Health - 2013-02-27
Emerging therapies for hepatic fibrosis
Friedman SL
http://www.uptodate.com/contents/emerging-therapies-for-hepatic-fibrosis
UpToDate, Wolters Kluwer Health - 2011-01-10
Pathogenesis of hepatic fibrosis
Friedman SL
http://www.uptodate.com/contents/pathogenesis-of-hepatic-fibrosis
UpToDate, Wolters Kluwer Health - 2012-08-23
Liver transplantation in alcoholic liver disease
Friedman SL
http://www.uptodate.com/contents/liver-transplantation-in-alcoholic-liver-disease
UpToDate, Wolters Kluwer Health - 2012-06-04
Pathogenesis of alcoholic liver disease
Friedman SL
http://www.uptodate.com/contents/pathogenesis-of-alcoholic-liver-disease
UpToDate, Wolters Kluwer Health - 2012-11-08
Join now to see all

Press Mentions

Statins Appear to Guard Against Liver Disease ProgressionMay 13th, 2023
Deadly Liver Disease Tied to Obesity Is on the RiseOctober 22nd, 2021
How to Take Care of Your LiverAugust 9th, 2021
Join now to see all

Grant Support

Role Of Stellate Cells In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases2011–2012
Autophagy During Hepatic Stellate Cell Activation In Alcoholic Liver InjuryNational Institute On Alcohol Abuse And Alcoholism2011
Project 2National Institute On Alcohol Abuse And Alcoholism2010–2011
Project 1National Institute On Alcohol Abuse And Alcoholism2010–2011
Pilot Feasibility Project #3National Institute On Alcohol Abuse And Alcoholism2010–2011
Pilot Feasibility Project #2National Institute On Alcohol Abuse And Alcoholism2010–2011
Pilot Feasibility Project #1National Institute On Alcohol Abuse And Alcoholism2010–2011
Oxidant Stress And Fibrosis In Alcoholic Liver InjuryNational Institute On Alcohol Abuse And Alcoholism2010–2011
Models CoreNational Institute On Alcohol Abuse And Alcoholism2010–2011
Mentoring Junior Faculty In Alcoholic Liver DiseaseNational Institute On Alcohol Abuse And Alcoholism2010–2011
Administrative CoreNational Institute On Alcohol Abuse And Alcoholism2010–2011
Training Program In Investigative GastroenterologyNational Institute Of Diabetes And Digestive And Kidney Diseases2010
The Role Of KLF6 Tumor Suppressor In Hepatocellular CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2010
Mentoring Junior Faculty In Alcoholic Liver DiseaseNational Institute On Alcohol Abuse And Alcoholism2009
International Symposium On Alcoholic Liver And Pancreatic Disease (ALPD)National Institute On Alcohol Abuse And Alcoholism2009
The Role Of KLF6 Tumor Suppressor In Hepatocellular CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2009
Project 2National Institute On Alcohol Abuse And Alcoholism2008–2009
Project 1National Institute On Alcohol Abuse And Alcoholism2008–2009
Pilot Feasibility Project #3National Institute On Alcohol Abuse And Alcoholism2008–2009
Pilot Feasibility Project #2National Institute On Alcohol Abuse And Alcoholism2008–2009
Pilot Feasibility Project #1National Institute On Alcohol Abuse And Alcoholism2008–2009
Oxidant Stress And Fibrosis In Alcoholic Liver InjuryNational Institute On Alcohol Abuse And Alcoholism2008–2009
Models CoreNational Institute On Alcohol Abuse And Alcoholism2008–2009
Administrative CoreNational Institute On Alcohol Abuse And Alcoholism2008–2009
The Role Of KLF6 In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
Training Program In Investigative GastroenterologyNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2009
Role Of KLF6 Tumor Suppressor In Hepatocellular CancerNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2007
DDR2 Receptor Tyrosine Kinase In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
The Role Of Stellate Cells In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003
Lipocytes And Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1997–1998
Lipocytes And Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1997
The Role Of Lipocytes In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1993
R0le Of Lipocytes In Hepatic Fibrosis 0National Institute Of Diabetes And Digestive And Kidney Diseases1992
Role Of Lipocytes In Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1990
The Role Of Lipocytes In Hepatic Collagen MetabolismNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985